Search

Your search keyword '"Curnis, A"' showing total 2,379 results

Search Constraints

Start Over You searched for: Author "Curnis, A" Remove constraint Author: "Curnis, A"
2,379 results on '"Curnis, A"'

Search Results

2. Magnetic resonance-conditional cardiac implantable electronic devices: an Italian perspective on the prevalence of mixed-brand systems over time

3. Magnetic resonance-conditional cardiac implantable electronic devices: an Italian perspective on the prevalence of mixed-brand systems over time

6. Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: Real-world insights from the iSUSI registry

7. H2FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation

9. A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: 12-Month results from the Micra AV post-approval registry

10. Device-detected atrial sensing amplitudes as a marker of increased risk for new onset and progression of atrial high-rate episodes

11. Cost-Utility Analysis of the EVOLVO Study on Remote Monitoring for Heart Failure Patients With Implantable Defibrillators: Randomized Controlled Trial

13. Implantable loop recorder in Brugada syndrome: Insights from a single-center experience

15. Long-Term Performance of Subcutaneous Implantable Defibrillators in Athletes: A Multicenter, Real-World Analysis of Sport Activities from the iSUSI Registry

16. Leadless pacemakers in patients with different stages of chronic kidney disease: Real-world data from the updated i-LEAPER registry

18. Sex differences in leadless pacemaker implantation: A propensity-matched analysis from the i-LEAPER registry

20. Outcomes of leadless pacemaker implantation following transvenous lead extraction in high-volume referral centers: Real-world data from a large international registry

21. One-year mortality after implantable defibrillator implantation: do risk stratification models help improving clinical practice?

22. Peri-procedural and mid-term follow-up age-related differences in leadless pacemaker implantation: Insights from a multicenter European registry

23. Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Therapy in Women: A Propensity Score-Matched Analysis

25. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator

28. Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry

30. Determinants of invasive left atrial pressure in patients with atrial fibrillation.

31. Sex differences in long‐term outcomes following transvenous lead extraction.

32. Gold nanorod-assisted theranostic solution for nonvisible residual disease in bladder cancer.

33. Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation

34. Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study

35. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience

36. Outcomes of leadless pacemaker in chronic kidney disease patients: real-world data from the i-LEAPER registry

37. Imaging-guided photothermal therapy for bladder cancer lesions smaller than 1 millimeter expressing marker of bladder CIS

41. Atrioventricular synchronous leadless pacemaker: state of art and broadened indications

43. Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy

44. GTASynth: 3D synthetic data of outdoor non-urban environments.

45. Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR/cytokine-coated nanogold

48. A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer

49. Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial

50. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up

Catalog

Books, media, physical & digital resources